Acquired cholesteatoma epithelial hyperproliferation: Roles of cell proliferation signal pathways

作者：Xie, Shumin; Xiang, Yuyan; Wang, Xiaoli; Ren, Hongmiao; Yin, Tuanfang; Ren, Jihao; Liu, Wei^*

来源：Laryngoscope, 2016, 126(8): 1923-1930.

DOI：10.1002/lary.25834

• Cholesteatoma
• cell proliferation
• therapy
• etiopathogenesis

Objectives/HypothesisTo review the recent cell proliferation signal pathways in the etiopathogenesis of acquired middle ear cholesteatoma.
Data SourcesPubMed (to September 2015).
Review MethodsArticles about cell proliferation signal pathways in the etiopathogenesis of acquired cholesteatoma and treatment advances were searched in the PubMed database, from which 73 were included in this review.
ResultsThe exact underlying cellular and molecular mechanism of acquired cholesteatoma still remains unknown. Recent research tends to regard the proliferation of cholesteatoma epithelial cells as the mechanism of cholesteatoma pathogenesis. Cell proliferation signal pathways including epidermal growth factor receptor/phosphoinositide 3-kinase/protein kinase B signal pathway, mitogen-activated protein kinase signal pathway, interleukin-6/signal transducer and activator of transcription 3 signal pathway, inhibitor of DNA binding/differentiation-1/nuclear factor-B/cyclinD1 signal pathway, microRNA-mediated proliferation signal pathway, and keratinocyte growth factor/keratinocyte growth factor receptor signal pathway have been proven to play important roles in acquired middle ear cholesteatoma.
ConclusionsThis review outlines the main biological properties of certain cell proliferation signal pathways, aiming to facilitate the development of potential therapeutic targets for intratympanic drug therapy for the nonsurgical or complementary treatment of cholesteatoma.
Level of EvidenceNA Laryngoscope, 126:1923-1930, 2016

• 出版日期2016-8
• 单位中南大学; 南华大学